News Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Related Stories News Bitzero Holdings Inc. Announces Refiling of Its Annual and Interim Financial Statements and MD&A News Ucore Announces Exercise of Warrants by Director and Full Repayment of Orca Debt Facilities News Alithya Announces Directors’ Election Results News VIQ Solutions Launches NetScribe(R) Live, a Real-Time Recording and Multi-Lingual Transcription Platform for Multiple Industry Applications News CEO.CA’s Inside the Boardroom: Inaugural Drilling Complete: Enduro Metals Prepares for Fall Assay Results News CEO.CA’s Inside the Boardroom: Why a Former GM Executive Left Automotive to Lead Scandium Canada